Brain astrocytes show metabolic alterations in Parkinson’s disease

Brain astrocytes show metabolic alterations in Parkinson’s disease: A new study using induced pluripotent stem cell (iPSC) technology links astrocyte dysfunction to Parkinson’s disease (PD) pathology. The study carried out at the University of Eastern Finland and published in Scientific Reports highlights the role of brain astrocyte cells in PD pathology and the potential of iPSC-derived cells […]

Read More… from Brain astrocytes show metabolic alterations in Parkinson’s disease

Brain astrocytes show metabolic alterations in Parkinson’s disease

Brain astrocytes show metabolic alterations in Parkinson’s disease: A new study using induced pluripotent stem cell (iPSC) technology links astrocyte dysfunction to Parkinson’s disease (PD) pathology. The study carried out at the University of Eastern Finland and published in Scientific Reports highlights the role of brain astrocyte cells in PD pathology and the potential of iPSC-derived cells […]

Read More… from Brain astrocytes show metabolic alterations in Parkinson’s disease

Fungus leather substitute could be eco-friendlier

“Promising” fungal leather substitute that looks and feels like traditional leather could be more sustainable and cheaper than animal and plastic versions. In a new review paper by the University of Vienna, Imperial College London, and RMIT University in Australia, researchers argue that leather made from fungi has “considerable potential” to be the best leather […]

Read More… from Fungus leather substitute could be eco-friendlier

Fungus leather substitute could be eco-friendlier

“Promising” fungal leather substitute that looks and feels like traditional leather could be more sustainable and cheaper than animal and plastic versions. In a new review paper by the University of Vienna, Imperial College London, and RMIT University in Australia, researchers argue that leather made from fungi has “considerable potential” to be the best leather […]

Read More… from Fungus leather substitute could be eco-friendlier

Private sector can help deliver UK’s infrastructure revolution

Private sector investment can be a major driver of the UK’s ‘infrastructure revolution’, says the CBI, at a time when public purses have been stretched by unprecedented Covid-19 support measures. Government spending plans unveiled in March’s Budget included historic £640billion infrastructure pledges designed to revitalise Britain’s roads, railways, broadband and housing as part of the […]

Read More… from Private sector can help deliver UK’s infrastructure revolution

Private sector can help deliver UK’s infrastructure revolution

Private sector investment can be a major driver of the UK’s ‘infrastructure revolution’, says the CBI, at a time when public purses have been stretched by unprecedented Covid-19 support measures. Government spending plans unveiled in March’s Budget included historic £640billion infrastructure pledges designed to revitalise Britain’s roads, railways, broadband and housing as part of the […]

Read More… from Private sector can help deliver UK’s infrastructure revolution

Rheumatoid Arthritis Awareness Week

This week marks Rheumatoid Arthritis Awareness Week, a week dedicated to increasing the profile of a frequently misunderstood disease that affects over 430,000 people in the UK. It is a common misconception that arthritis is simply a condition of the elderly, a consequence of age and subsequent wear and tear of the joints. However, Rheumatoid […]

Read More… from Rheumatoid Arthritis Awareness Week

Rheumatoid Arthritis Awareness Week

This week marks Rheumatoid Arthritis Awareness Week, a week dedicated to increasing the profile of a frequently misunderstood disease that affects over 430,000 people in the UK. It is a common misconception that arthritis is simply a condition of the elderly, a consequence of age and subsequent wear and tear of the joints. However, Rheumatoid […]

Read More… from Rheumatoid Arthritis Awareness Week

Gout medicine halts progression of coronary disease

Common medicine used to treat gout found to prevent progression of coronary disease – international study published in New England Journal of Medicine by Perth researchers. A major clinical trial involving 5,500 patients in Australia and the Netherlands found heart attacks and the need for coronary stenting or bypass surgery reduced by 30% in patients […]

Read More… from Gout medicine halts progression of coronary disease

Gout medicine halts progression of coronary disease

Common medicine used to treat gout found to prevent progression of coronary disease – international study published in New England Journal of Medicine by Perth researchers. A major clinical trial involving 5,500 patients in Australia and the Netherlands found heart attacks and the need for coronary stenting or bypass surgery reduced by 30% in patients […]

Read More… from Gout medicine halts progression of coronary disease